glp 1 and substance use disorder GLP-1 receptor agonists disorders: new large-scale evidence from the BMJ A cohort study published in the BMJ this week (Cai, Choi, Xie, Al-Aly, 2026) examined over 600,000 US veterans GLP-1 weight-loss drugs show early

The current treatment for osteoporosis is mainly the inhibition of bone resorption

medscape.com To view or add a comment, sign in I wanted to share key take-aways from the recent joint statement by hepatology and diabetes experts: Management of patients with type 2 diabetes and MASLD: an overview and joint statement (Chouik Y et al., 2025)

Las personas que toman GLP-1 tienen que adoptar hbitos saludables, como el ejercicio y una dieta equilibrada

A long road is ahead of us to better understand the complexity of HFpEF, but a comprehensive multimarker approach may be recommended to characterise specific HFpEF phenotypes/endotypes for optimising therapy and to stratify risk